Finance Watch: Merrimack And LianBio Are Latest To Liquidate As Options Run Out
Synlogic, Rallybio And Others Reveal Workforce Reductions
Restructuring Edition: The financial market is beginning to perk up after a decline in biopharma financings at the end of 2023, but some companies still are struggling to stay afloat after assessing their strategic options, like Merrimack and LianBio, which announced plans to dissolve.
